mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young Adults | MicrobiomeTrials← Back to trialsNCT07557602
mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young Adults
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-11-16Est. Completion: 2028-02-29
Enrollment target: 82 participants Locations- Q-Pharm Pty Ltd/Nucleus Network Pty Ltd, Herston, Queensland, Australia
- Nucleus Network Pty Ltd, Melbourne, Victoria, Australia
Other microbiome trials you might be interested in
Relapsed Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaB-cell Acute Lymphoblastic LeukemiaPediatric CancerPediatric ALL, RelapsedPediatric ALLPediatric ALL, B CellAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaPediatric AMLR/R AMLR/R B-cell ALL
The goal of this clinical trial is to learn if sonrotoclax (BGB-11417) is safe and may help treat children and adolescen…
Multiple LocationsEst. completion Apr 30, 2030
Phase 3
Recruiting
B-Cell Acute Lymphoblastic Leukaemia
The IntReALL BCP 2020 study aims to review recent developments and findings regarding chemoimmunotherapy with inotuzumab…
Vienna, AustriaEst. completion Mar 31, 2033